(2026). Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model. Molecular Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Dual PI3K/AKT and CDK4/6 Inhibition Reveals Selective Sensitivity in an SHH Medulloblastoma Stem Cell Model."
Molecular Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Dual PI3K/AKT and CDK4/6 Inhibition Reveals Selective Sensitivity in an SHH Medulloblastoma Stem Cell Model."
Molecular Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.